Paysign Q3FY26 Results: Earnings call scheduled for November 9, 2026

0 min read | Published on 14 Oct 2026, 03:35 AM |Updated on 14 Oct 2026, 03:35 AM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

Paysign Inc. will discuss Q3FY26 results on November 9, 2026
Conference call starts at 5:00 pm Eastern time
Analysts must register by November 6 to ask questions
Replay available until January 25, 2027

*this image is generated using AI for illustrative purposes only.

Paysign Inc. announced it will hold a conference call to discuss its financial results for the third quarter of fiscal year 2026 on Monday, November 9, 2026, at 5:00 pm Eastern time.

The company, which operates in the fintech and healthcare sectors providing patient affordability and donor compensation solutions, has set specific dial-in and webcast details for investors and analysts.

Call participation details

Interested parties can access the live webcast or dial in using the following information:

Method	Details
U.S. Dial-in	877.407.2988
International Dial-in	+1.201.389.0923
Webcast Link	Available via company investor relations portal

Replay availability

A replay of the earnings call will be available after the event concludes. Participants can access the replay using the details below until January 25, 2027:

Dial-in: 877.660.6853 or +1.201.612.7415
Conference ID: 13763287

Analyst registration

Financial professionals wishing to ask questions during the Q&A session must register in advance. Registration requires emailing the company's investor relations team no later than 5:00 pm Eastern time on Friday, November 6, 2026.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might recent regulatory changes in healthcare affordability impact Paysign's projected revenue growth for the upcoming fiscal year?

What specific strategic partnerships in the fintech sector is management expected to announce to drive expansion beyond the current quarter?

How are rising interest rates affecting the company's cost of capital and its ability to fund new donor compensation initiatives?

View Company Insights

View All News

Paysign to present at Midwest IDEAS Investor Conference in Chicago

0 min read | Published on 18 Aug 2026, 06:40 PM |Updated on 18 Aug 2026, 06:40 PM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

Key Highlights

Paysign, Inc. (NASDAQ: PAYS) will attend the 17th Annual Midwest IDEAS Investor Conference in Chicago this August. CEO Mark Newcomer and CFO Jeff Baker will meet with institutional investors.

*this image is generated using AI for illustrative purposes only.

Paysign, Inc. (NASDAQ: PAYS) will present at the 17th Annual Midwest IDEAS Investor Conference, scheduled for August 26-27, 2026, at the InterContinental in Chicago, Illinois. The fintech and healthcare provider aims to engage directly with institutional investors through the invitation-only event.

Executive Participation

Senior leadership from Paysign will be available for one-on-one and group meetings throughout the conference. The attendees include:

Mark Newcomer, President and Chief Executive Officer
Jeff Baker, Chief Financial Officer
Matt Turner, President of Patient Affordability

The conference format is designed to provide attendees with direct access to senior management. IDEAS Investor Conferences are sponsored by investors for investors, featuring sponsors with more than $200 billion in assets under management.

About Paysign

Paysign operates at the intersection of fintech and healthcare, integrating payment processing and program management technologies for the plasma, pharmaceutical, and life sciences industries. The company provides patient affordability solutions, donor compensation programs, and engagement platforms. Its proprietary processing architecture supports physical, virtual, mobile, and bank-based payments with real-time transaction intelligence.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the insights shared by Paysign's leadership at the IDEAS conference influence institutional investor sentiment and short-term stock volatility for PAYS?

What specific strategic initiatives in patient affordability or plasma donor compensation is Matt Turner likely to highlight as growth drivers for 2027?

Could the direct engagement with investors managing over $200 billion in assets lead to immediate changes in Paysign's capital allocation or M&A strategy?

View Company Insights

View All News